The global cancer screening market is anticipated to grow at a CAGR of 10.0% during the forecast period. The rising prevalence of cancer is the major factor behind the rising demand for cancer screening globally. The awareness programs initiated by governments across the globe for early diagnosis and treatment of cancer are also supporting the growth of the market. For instance, in November 2018, the European Commission announced the availability of the European Commission Initiative on Breast Cancer (ECIBC) recommendations about breast cancer imaging and diagnosis. The ECIBC develops the European Breast Guidelines, evidence-based references to provide women and healthcare providers with bright, objective, and individualistic guidance on breast cancer screening and diagnosis.
Get Free Sample link @ https://www.omrglobal.com/request-sample/cancer-screening-market
However, the high cost associated with the cancer screening types may hamper the growth of the market in developing countries due to the lower disposable income. This report will further analyze all the primary and secondary factors that are directly or indirectly influencing the growth of the cancer screening market during the forecast period.
A full report of Global Cancer Screening Market available @ https://www.omrglobal.com/industry-reports/cancer-screening-market
- Market Coverage
- Market number available for – 2022-2028
- Base year- 2021
- Forecast period- 2022-2028
- Segment Covered- By Source, By Product Type, By Applications
- Competitive Landscape- Archer Daniels Midland Co., Ingredion Inc., Kerry Group Plc, Cargill Inc., and others
Market Segmentation
Global Cancer Screening Market by Screening Type
- Diagnostic Imaging Tests
- Biopsy & Cytology Tests
- Tumor Biomarkers
- Others
Global Cancer Screening Market by Application
- Breast Cancer
- Lung Cancer
- Cervical Cancer
- Kidney Cancer
- Liver Cancer
- Pancreatic Cancer
- Ovarian Cancer
- Others
Regional Analysis
- North America
- US
- Canada
- Europe
- UK
- Germany
- Italy
- Spain
- France
- Rest of Europe
- Asia-Pacific
- China
- India
- Japan
- Rest of Asia-Pacific
- Rest of the World
Company Profiles
- Becton, Dickinson, and Co.
- Bio-Rad Laboratories Inc.
- Cancer Diagnostic Inc.
- DiaSorin S.p.A.
- Epigenomics AG
- Hologic Inc.
- Illumina Inc.
- MedGenome Labs Ltd.
- Positive Biosciences Ltd.
- QIAGEN GmbH
- Siemens Healthineers AG
- Techlab, Inc.
- VolitionRX Ltd.
- 20/20 GeneSystems
The Report Covers
- Market value data analysis of 2021 and forecast to 2028.
- Annualized market revenues ($ million) for each market segment.
- Country-wise analysis of major geographical regions.
- Key companies operating in the global cancer screening market. Based on the availability of data, information related to new product launches, and relevant news is also available in the report.
- Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
- Analysis of market-entry and market expansion strategies.
- Competitive strategies by identifying ‘who-stands-where’ in the market.
For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/cancer-screening-market
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 780-304-0404
